Moreover, IL-6 upregulates the expression of C-motif chemokine receptor (CCR) 5 on MDSC leading to their recruitment to the tumor site and enhanced inhibitory activity towards CD8+ T cells (30). This evidence concerns the gene CD8A and neoplasm.